GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

Arexvy has been approved in Malaysia for RSV (respiratory syncytial virus), for older adults aged 60 and above. The vaccine ...

Cancer Vaccines Market revenue is expected to hold around USD 24.22 billion by 2033 from USD 9 million in 2023 with a ...

Falak is a newly built Grade A office building located in the heart of Dubai Internet City (DIC), offering over 90,000 square ...

DoctorsOfJoy aims to highlight how dentists empower individuals to fully enjoy life's moments by addressing oral health ...

NewZNew - Sensodyne Celebrates World Dentist Day with #DoctorsOfJoy Campaign: Sensodyne, a leading oral care brand from ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK – Research Report), Sonova Holding AG (CH:SOON – Research Report) and Corbus Pharmaceuticals ...

The 13 drugs most likely to be chosen for CMS negotiations, according to the study: Ozempic, Rybelsus and Wegovy (semaglutide): Novo Nordisk's treatment for Type 2 diabetes and weight management.

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

The former head of vaccine R&D at GSK has pulled together $100 million for a London-based biotech working on respiratory ...

The Gates Foundation-funded Gavi immunization programme introduced the GlaxoSmithKline (GSK) Mosquirix vaccine in three ...